Work

Strategy for Validation of New Mycoplasma Nucleic Acid Detection Closed System and It Use in Routine Biopharmaceutical Manufacturing.

Year: 2025

Type: article

Source: PDA Journal of Pharmaceutical Science and Technology

DOI: 10.5731/pdajpst.2025-000023.1

Authors: Caroline Kassim Houssenaly, Samad Amini-Bavil-Olyaee, Carlos Salas Chung, Chakameh Azimpour, Ryan Pachucki, Orm Niewenhuizen, Karen De Roy, Zhihua Liu, Berenice Westrek-Esselink, Celine Vanmasstright, Marine Marius, Felix Alejandro Montero Julian

Institutions: bioMérieux (France), Amgen (United States), Bristol-Myers Squibb (United States), Kite Pharma (United States), MSD (Netherlands), Sanofi (France)

Language: English

Topic: Microbial infections and disease research

Subfield: Microbiology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414277287

FWCI:

Cites:

Cited by:

Related to: